The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Metabolomics Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Global Metabolomics Market 2024 by Company, Regions, Type and Application, Forecast to 2029

Publishing Date : Jul, 2023

License Type :
 

Report Code : 1638311

No of Pages : 102

Ask Your Query

Synopsis
The global Metabolomics market size was valued at USD 2197.8 million in 2022 and is forecast to a readjusted size of USD 4964.5 million by 2029 with a CAGR of 12.3% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

The key manufacturers of Metabolomics include Thermo Fisher, Agilent, Metabolon, Shimadzu, Corporation, Bruker, Waters Corporation, etc. Among them, Thermo Fisher and Agilent rank first and second in the world market share, about 12% and 9% respectively.

The market of metabolomics is distributed all over the world, with North America, Europe and Asia Pacific as the major markets. The North American market share reached more than 40%, ranking first in the world.

In terms of product, it include Metabolomics Instruments as well as Bioinformatics Tools and Services. The world market share of the two parts is about 2:1. It is expected that Bioinformatics Tools and Services' market share will increase relatively in the future.

Metabolomics is mainly used in academic and research institutes, pharmaceutical and biotechnology companies, contract research organizations, and other institutional organizations. Among them, academic and research institutions occupy the highest market share, accounting for more than 45%. In the Chinese market, the share of academic and research institutions has reached more than 50%.

This report is a detailed and comprehensive analysis for global Metabolomics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by End User. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

  • Global Metabolomics market size and forecasts, in consumption value ($ Million), 2018-2029
  • Global Metabolomics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
  • Global Metabolomics market size and forecasts, by Type and by End User, in consumption value ($ Million), 2018-2029
  • Global Metabolomics market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

  • To determine the size of the total market opportunity of global and key countries
  • To assess the growth potential for Metabolomics
  • To forecast future growth in each product and end-use market
  • To assess competitive factors affecting the marketplace

This report profiles key players in the global Metabolomics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Thermo Fisher, Agilent, Metabolon, Shimadzu Corporation and Bruker, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Metabolomics market is split by Type and by End User. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by End User. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type

  • Metabolomics Instruments
  • Bioinformatics Tools and Services

Market segment by End User

  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations

Market segment by players, this report covers

  • Thermo Fisher
  • Agilent
  • Metabolon
  • Shimadzu Corporation
  • Bruker
  • Waters Corporation
  • Biotree
  • LECO Corporation
  • Biocrates Life Sciences AG
  • Human Metabolome Technologies
  • Metware
  • Applied Protein Technology
  • Creative Proteomics
  • Diagnostic Solutions Laboratory

Market segment by regions, regional analysis covers

  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Metabolomics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Metabolomics, with revenue, gross margin and global market share of Metabolomics from 2018 to 2023.
Chapter 3, the Metabolomics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Metabolomics market forecast, by regions, type and end user, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Metabolomics.
Chapter 13, to describe Metabolomics research findings and conclusion.

Index

1 Market Overview
1.1 Product Overview and Scope of Metabolomics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Metabolomics by Type
1.3.1 Overview: Global Metabolomics Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Metabolomics Consumption Value Market Share by Type in 2022
1.3.3 Metabolomics Instruments
1.3.4 Bioinformatics Tools and Services
1.4 Global Metabolomics Market by End User
1.4.1 Overview: Global Metabolomics Market Size by End User: 2018 Versus 2022 Versus 2029
1.4.2 Academic and Research Institutes
1.4.3 Pharmaceutical and Biotechnology Companies
1.4.4 Contract Research Organizations
1.5 Global Metabolomics Market Size & Forecast
1.6 Global Metabolomics Market Size and Forecast by Region
1.6.1 Global Metabolomics Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Metabolomics Market Size by Region, (2018-2029)
1.6.3 North America Metabolomics Market Size and Prospect (2018-2029)
1.6.4 Europe Metabolomics Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Metabolomics Market Size and Prospect (2018-2029)
1.6.6 South America Metabolomics Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Metabolomics Market Size and Prospect (2018-2029)
2 Company Profiles
2.1 Thermo Fisher
2.1.1 Thermo Fisher Details
2.1.2 Thermo Fisher Major Business
2.1.3 Thermo Fisher Metabolomics Product and Solutions
2.1.4 Thermo Fisher Metabolomics Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Thermo Fisher Recent Developments and Future Plans
2.2 Agilent
2.2.1 Agilent Details
2.2.2 Agilent Major Business
2.2.3 Agilent Metabolomics Product and Solutions
2.2.4 Agilent Metabolomics Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Agilent Recent Developments and Future Plans
2.3 Metabolon
2.3.1 Metabolon Details
2.3.2 Metabolon Major Business
2.3.3 Metabolon Metabolomics Product and Solutions
2.3.4 Metabolon Metabolomics Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Metabolon Recent Developments and Future Plans
2.4 Shimadzu Corporation
2.4.1 Shimadzu Corporation Details
2.4.2 Shimadzu Corporation Major Business
2.4.3 Shimadzu Corporation Metabolomics Product and Solutions
2.4.4 Shimadzu Corporation Metabolomics Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Shimadzu Corporation Recent Developments and Future Plans
2.5 Bruker
2.5.1 Bruker Details
2.5.2 Bruker Major Business
2.5.3 Bruker Metabolomics Product and Solutions
2.5.4 Bruker Metabolomics Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Bruker Recent Developments and Future Plans
2.6 Waters Corporation
2.6.1 Waters Corporation Details
2.6.2 Waters Corporation Major Business
2.6.3 Waters Corporation Metabolomics Product and Solutions
2.6.4 Waters Corporation Metabolomics Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Waters Corporation Recent Developments and Future Plans
2.7 Biotree
2.7.1 Biotree Details
2.7.2 Biotree Major Business
2.7.3 Biotree Metabolomics Product and Solutions
2.7.4 Biotree Metabolomics Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Biotree Recent Developments and Future Plans
2.8 LECO Corporation
2.8.1 LECO Corporation Details
2.8.2 LECO Corporation Major Business
2.8.3 LECO Corporation Metabolomics Product and Solutions
2.8.4 LECO Corporation Metabolomics Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 LECO Corporation Recent Developments and Future Plans
2.9 Biocrates Life Sciences AG
2.9.1 Biocrates Life Sciences AG Details
2.9.2 Biocrates Life Sciences AG Major Business
2.9.3 Biocrates Life Sciences AG Metabolomics Product and Solutions
2.9.4 Biocrates Life Sciences AG Metabolomics Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Biocrates Life Sciences AG Recent Developments and Future Plans
2.10 Human Metabolome Technologies
2.10.1 Human Metabolome Technologies Details
2.10.2 Human Metabolome Technologies Major Business
2.10.3 Human Metabolome Technologies Metabolomics Product and Solutions
2.10.4 Human Metabolome Technologies Metabolomics Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Human Metabolome Technologies Recent Developments and Future Plans
2.11 Metware
2.11.1 Metware Details
2.11.2 Metware Major Business
2.11.3 Metware Metabolomics Product and Solutions
2.11.4 Metware Metabolomics Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Metware Recent Developments and Future Plans
2.12 Applied Protein Technology
2.12.1 Applied Protein Technology Details
2.12.2 Applied Protein Technology Major Business
2.12.3 Applied Protein Technology Metabolomics Product and Solutions
2.12.4 Applied Protein Technology Metabolomics Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Applied Protein Technology Recent Developments and Future Plans
2.13 Creative Proteomics
2.13.1 Creative Proteomics Details
2.13.2 Creative Proteomics Major Business
2.13.3 Creative Proteomics Metabolomics Product and Solutions
2.13.4 Creative Proteomics Metabolomics Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Creative Proteomics Recent Developments and Future Plans
2.14 Diagnostic Solutions Laboratory
2.14.1 Diagnostic Solutions Laboratory Details
2.14.2 Diagnostic Solutions Laboratory Major Business
2.14.3 Diagnostic Solutions Laboratory Metabolomics Product and Solutions
2.14.4 Diagnostic Solutions Laboratory Metabolomics Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Diagnostic Solutions Laboratory Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Metabolomics Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Metabolomics by Company Revenue
3.2.2 Top 3 Metabolomics Players Market Share in 2022
3.2.3 Top 6 Metabolomics Players Market Share in 2022
3.3 Metabolomics Market: Overall Company Footprint Analysis
3.3.1 Metabolomics Market: Region Footprint
3.3.2 Metabolomics Market: Company Product Type Footprint
3.3.3 Metabolomics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Metabolomics Consumption Value and Market Share by Type (2018-2023)
4.2 Global Metabolomics Market Forecast by Type (2024-2029)
5 Market Size Segment by End User
5.1 Global Metabolomics Consumption Value Market Share by End User (2018-2023)
5.2 Global Metabolomics Market Forecast by End User (2024-2029)
6 North America
6.1 North America Metabolomics Consumption Value by Type (2018-2029)
6.2 North America Metabolomics Consumption Value by End User (2018-2029)
6.3 North America Metabolomics Market Size by Country
6.3.1 North America Metabolomics Consumption Value by Country (2018-2029)
6.3.2 United States Metabolomics Market Size and Forecast (2018-2029)
6.3.3 Canada Metabolomics Market Size and Forecast (2018-2029)
6.3.4 Mexico Metabolomics Market Size and Forecast (2018-2029)
7 Europe
7.1 Europe Metabolomics Consumption Value by Type (2018-2029)
7.2 Europe Metabolomics Consumption Value by End User (2018-2029)
7.3 Europe Metabolomics Market Size by Country
7.3.1 Europe Metabolomics Consumption Value by Country (2018-2029)
7.3.2 Germany Metabolomics Market Size and Forecast (2018-2029)
7.3.3 France Metabolomics Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Metabolomics Market Size and Forecast (2018-2029)
7.3.5 Russia Metabolomics Market Size and Forecast (2018-2029)
7.3.6 Italy Metabolomics Market Size and Forecast (2018-2029)
8 Asia-Pacific
8.1 Asia-Pacific Metabolomics Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Metabolomics Consumption Value by End User (2018-2029)
8.3 Asia-Pacific Metabolomics Market Size by Region
8.3.1 Asia-Pacific Metabolomics Consumption Value by Region (2018-2029)
8.3.2 China Metabolomics Market Size and Forecast (2018-2029)
8.3.3 Japan Metabolomics Market Size and Forecast (2018-2029)
8.3.4 South Korea Metabolomics Market Size and Forecast (2018-2029)
8.3.5 India Metabolomics Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Metabolomics Market Size and Forecast (2018-2029)
8.3.7 Australia Metabolomics Market Size and Forecast (2018-2029)
9 South America
9.1 South America Metabolomics Consumption Value by Type (2018-2029)
9.2 South America Metabolomics Consumption Value by End User (2018-2029)
9.3 South America Metabolomics Market Size by Country
9.3.1 South America Metabolomics Consumption Value by Country (2018-2029)
9.3.2 Brazil Metabolomics Market Size and Forecast (2018-2029)
9.3.3 Argentina Metabolomics Market Size and Forecast (2018-2029)
10 Middle East & Africa
10.1 Middle East & Africa Metabolomics Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Metabolomics Consumption Value by End User (2018-2029)
10.3 Middle East & Africa Metabolomics Market Size by Country
10.3.1 Middle East & Africa Metabolomics Consumption Value by Country (2018-2029)
10.3.2 Turkey Metabolomics Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Metabolomics Market Size and Forecast (2018-2029)
10.3.4 UAE Metabolomics Market Size and Forecast (2018-2029)
11 Market Dynamics
11.1 Metabolomics Market Drivers
11.2 Metabolomics Market Restraints
11.3 Metabolomics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 Industry Chain Analysis
12.1 Metabolomics Industry Chain
12.2 Metabolomics Upstream Analysis
12.3 Metabolomics Midstream Analysis
12.4 Metabolomics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

Published By : GlobalInfoResearch

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock